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Abstract 
A wound gets infected when the organism gets invaded through the breached skin, proliferated and production of various 
enzymes, toxins, etc. In order to treat the wound infection, antibiotic susceptibility pattern of organism should be determined 
before the prescription of the medicine. The present study was conducted from September 2017 to March 2018 with an aim to 
determine antibiotic susceptibility pattern of Staphylococcus aureus identified from the pus/wound swab among the patients 
visiting the International Friendship Children's Hospital, Kathmandu, Nepal. Total 270 sample were processed, isolated and 
identified using standard microbiological procedure and biochemical test. Antibiotic susceptibility test was carried out by 
using Modified Kirby Bauer's Disc Diffusion Method. Out of total sample, 51.48% (139) showed growth. The growth 
distribution was found to be high in out-patient department 84.9% (118) than in-patient department 15.1% (21). Among 139 
positive growth, 83.5% were gram positive and 16.5% were gram negative. All together 12 different organisms were identified, 
among which S. aureus was found to be predominant organism 105 (75.5%). S. aureus was found to be sensitive towards 
Linezolid followed by Doxycycline whereas it was found resistant towards Ciprofloxacin. Among S. aureus identified, 50% 
were Multidrug resistant (MDR) S. aureus and 55% were Methicillin resistance S. aureus (MRSA). MRSA was found to be 
sensitive towards Linezolid followed by Doxycycline and resistant towards Ciprofloxacin. The association between MDR and 
MRSA was found positively significant (i.e. p-value = 0.000). All strains of S. aureus were found to be sensitive towards 
Vancomycin.  22.86% were double disk diffusion test (D-test) positive. The prevalence of D-test was found to be high in MRSA 
(75%). The relationship between D-test and MRSA was found to be significantly correlated with each other (r = 0.39). 
Linezolid, Chloramphenicol, Vancomycin and Doxycycline is a drug of a choice for both S. aureus and MRSA infection. 
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Introduction 
Human skin acts as an excellent barrier to infection, 
protect underlying tissues, bones, organs, etc. and 
prevents the entry of microbes (i.e. potential pathogens) 
into our body unless the mechanism is breached due to 
injury, trauma or surgical intervention [1, 2, 3]. A break 
in the integrity of the skin or tissues which may be 
associated with disruption of the structure and 
compromises its protective function is called a wound [4]. 
A wound gets infected when proliferating 
microorganisms invade to a level that invokes a local or 
systemic response in the host [5]. During wound 
infection, the bacteria multiplies, healing is disrupted and 
wound tissues get damage and also spread to nearby 
tissues. The consequences of any tissue damage, wound 
infection or any internal tissue injury is pus [6]. Pus is 
defined as the accumulation of dead cells and 
microorganisms, together with accumulated fluid and 
various proteins [7]. 
Wound infection is a common problem during injury, 
mainly in the case of children [4, 8]. Injuries in the 
children may be due to falls followed by burns, cuts and 
animal bites which causes both financial and 
psychological strain on the family because it drags the 
patient to the health care facilities [9, 10]. Wound 
infection account for 70-80% mortality and also an 
important cause of morbidity among surgical patients 
and 75% of mortality following burn injuries [11, 12, 13]. 
The common organism responsible for pus formation or 
wound infection are: Coagulase negative S. aureus 
(CONS). S. aureus, Bacillus spp., Clostridium spp., 
Peptostreptococcus spp., Actinomyces spp., E. coli, Proteus 
spp., Neisseria spp., Vibrio vulnificus, Candida spp., etc. 
[14]. 
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S. aureus is a versatile pathogen capable of causing a wide 
range of human diseases [15]. It is a significant human 
pathogen that causes wound infection, soft tissue 
infection and produces the pus [16, 17]. It belongs to the 
family Micrococcaceae, gram positive cocci having grape 
like cluster arrangement of 0.5-1.5 µm diameter, aerobic, 
facultatively anaerobic, ꞵ-hemolytic, fermentative, 
oxidase negative, non-sporing, non-motile, non-
capsulated, yellow zone formation around the colonies 
on MSA and oil paint appearance on NA slopes [18, 19]. 
There has been a huge problem all over the world in the 
treatment of infectious disease due to increase in 
antibiotic resistant cases [20]. Multi-drug resistant (MDR) 
is defined as the non-susceptibility of organism to at least 
one agent in 3 or more antimicrobial categories, 
extremely drug resistance (XDR) is non-susceptibility to 
at least 1 agent in all but 2 or fewer antimicrobial 
categories and pan drug resistance (PDR) is non-
susceptibility to all agents in all antimicrobial categories 
[21]. Methicillin resistant S. aureus (MRSA) has been 
identified as one of the major risk pathogens associated 
with the development of antimicrobial resistant [22]. 
MRSA is defined as a strain of S. aureus that is resistant to 
a large group of antibiotics called ꞵ-lactams, which 
include Penicillin and Cephalosporin [23]. In Nepal, 
various laboratories have reported the emergence of 
MRSA mainly community-associated MRSA (CAMRSA) 
which have been detected in the Lumbini medical college 
and teaching hospital while doing cross-sectional studies 
of prevalence of MRSA [24]. In another study, study 
carried out to assess the extent of MRSA in the 
Kathmandu Model Hospital Kathmandu, MRSA were 
more frequently isolated from pus samples and that too 
from hospitalized patients [23]. 
Vancomycin is a glycopeptide antibiotic that inhibits cell 
wall biosynthesis, remains a drug of choice for treatment 
of severe MRSA infections. S. aureus isolates with 
complete resistance to Vancomycin (MIC≥16µg/ml) are 
termed as Vancomycin resistant S. aureus (VRSA). VRSA 
was first reported in the U.S in 2002 [25]. In one of the 
studies conducted in the Manmohan Memorial College 
and Teaching Hospital, Kathmandu, Nepal, there all the 
MRSA identified was found to be susceptible towards the 
Vancomycin [26]. 
D-test is a simple disc diffusion test to study the 
macrolide lincosamide streptogramin B resistance 
(MLSB), both constitutive and inducible as well as 
macrolide streptogramin B resistance (MSB) in S. aureus. 
Macrolide group (Erythromycin, Azithromycin, 
Rokitamycin) is a drug used to treat of S. aureus infection 
and also used for those allergic to the Penicillin [24]. After 
a few years of drug's introduction in therapy, 
staphylococci developed resistance to Erythromycin in 
1956. These resistant strains were found in France, U.K 
and in the U.S.A [27]. Lincosamide (Clindamycin) is used 
for the treatment of MRSA infection [28]. Since these both 
antibiotics have the same site of drug target, there is a 
high chance of cross resistant among these antibiotics due 
to modification of drug target [29]. This study helps to 
perceive the current status in prevalence of S. aureus in 
pus/wound swab, the antibiotic susceptibility pattern of 
the isolated S. aureus and also any presence of multidrug 
resistant strain among the isolates. It also helps to know 
the resistant towards commonly used antibiotic and 
aware the practitioner from misusing the antibiotic. 
Hence, the aim of the study was to assess the prevalence 
of S. aureus and the antibiotic susceptibility pattern of S. 
aureus isolated from the pus/wound swab from children 
attending International Friendship Children's Hospital 
(IFCH), Maharajgunj, Kathmandu. 
Materials and Methods 
Sample collection and identification of 
isolates 
The research was conducted at the Microbiology 
Laboratory of International Friendship Children's 
Hospital, Maharajgunj, Kathmandu from September 2017 
to March 2018. A hospital based cross-sectional study 
was carried out among the patients visiting to the 
hospital having wound infection below 16 years, 
requesting for culture and susceptibility testing.  
In total, 270 pus/wound swab samples were collected 
using aseptic technique. Out of total sample, 228 samples 
were collected from out-patient department (OPD) and 
42 samples were collected from in-patient department 
(IPD). Within IPD also, 12 samples were collected from 
general ward (GW), 4 samples from special ward (Sp. 
ward), 12 samples from surgical/burn ward (S/B ward), 
6 samples from infant ICU (IICU), 3 samples from 
pediatric ICU (PICU), 4 samples surgical ICU (SICU) and 
1 sample from neonates ICU (NICU). Here, 130 samples 
were of male and 140 samples were of female. 17 samples 
were of age group 0-1 month, 54 of 1 month-1year, 75 of 
1-3 years, 54 of 4-6 years, 57 of 6-12 years and 13 of 12-15 
years.  
The specimens were well labelled and then transported 
to the laboratory and processed immediately. After 
macroscopic and microscopic observation, it was 
cultured on Blood Agar (BA) and Mac-Conkey Agar 
(MA) and incubated at 37°C for 24 hrs. The isolates were 
identified by colony morphology, gram staining and 
Nepal J Biotechnol. 2021  Jul ;9 (1):8 -17    Maharjan et al.      
©NJB, BSN 10 
various biochemical tests [30]. The gram-positive cocci in 
cluster observed under microscope was considered as 
Staphylococcus species and was subjected under different 
biochemical test for the confirmation of S. aureus. The 
Staphylococcus species showing catalase positive, oxidase 
negative, fermentative, yellow colony on mannitol salt 
agar (MSA), coagulase positive and DNase positive were 
confirmed as S. aureus [30]. For gram negative organism, 
different biochemical tests such as: catalase test, oxidase 
test, Sulphur Indole Motility (SIM) test, methyl red (MR) 
test, Voges-Proskauer (VP) test, citrate test, 
oxidative/fermentative (O/F) test, urease test and triple 
sugar iron (TSIA) test were performed for the 
identification of the organism.  
Antibiotic susceptibility test 
The antibiotic susceptibility testing was done by using 
modified Kirby-Bauer disc diffusion method [31] on 
Mueller Hinton agar using antibiotic discs of Hi-Media 
Laboratories Pvt. Ltd. The antibiotic used was selected by 
following Clinical and Laboratory Standards Institute 
(CLSI) 2017 guideline [31] for S. aureus. The antibiotics 
used were Cotrimoxazole (1.25/23 mcg), 
Chloramphenicol (30 mcg), Ciprofloxacin (5 mcg), 
Gentamycin (10 mcg), Doxycycline (30 mcg), Linezolid 
(30 mcg), Vancomycin (30 mcg), Azithromycin (15 mcg), 
Meropenem (10 mcg) and Piperacillin (100/10 mcg). 
Novobiocin (30 mcg) was used to identify S. epidermidis 
and S. saprophyticus. If the identified S. aureus was found 
to be resistant to at least one agent in three or more 
antimicrobial categories, then the organism was 
considered as multidrug resistant (MDR) and if the 
identified S. aureus was found to be resistant to at least 1 
agent in all but 2 or fewer antimicrobial categories, then 
it was considered as extremely drug resistant (XDR) [21]. 
After screening MDR, the identified S. aureus was then 
screened for Methicillin resistant S. aureus (MRSA) using 
Cefoxitin disc (30 mcg).The organisms resistant i.e. ≤21 
mm Zone of inhibition (ZOI) towards the Cefoxitin were 
confirmed as MRSA and those sensitive were confirmed 
as Methicillin sensitive S. aureus (MSSA) [25]. If the 
organism was found to be Vancomycin resistant in disc 
diffusion method, it was further processed for the 
confirmation of Vancomycin resistant S. aureus (VRSA) 
by using minimum inhibitory concentration (MIC) 
method [31]. S. aureus ATCC 25923 was used as control 
strain. 
D-test 
D-test was performed by using Erythromycin disc (15 
mcg) and Clindamycin disc (2 mcg). The antibiotic discs 
were placed on a lawn cultured MHA plate at 15 mm 
apart and was incubated at 37° C at 18-24 hrs [24]. The 
organisms that showed flattening zone of Clindamycin 
adjacent to the Erythromycin disc were considered as D-
test positive (MLSBi resistant, i.e. Inducible macrolide-
lincosamide-streptogramin B resistance). If the organism 
was found to be resistant towards both discs then, it was 
taken as Constitutive MLSB (MLSBc) and if organism 
showed sensitive towards Clindamycin but resistant 
towards Erythromycin, then it was taken as D-test 
negative [24]. 
Data analysis 
All the data was entered in Statistical Package for the 
Social Science (SPSS) version 16. Most of the data was 
analysed by using SPSS version 16 (SPSS for Windows, 
Chicago, SPSS Inc). The association between MDR and 
MRSA was determined by performing chi-square test 
analysed by SPSS version 16 whereas the correlation 
coefficient between D-test and MRSA was calculated by 
using statistical method, i.e. Karl Pearson's correlation 
coefficient. In the study, we used Pearson's chi-square 
test to test whether MRSA influences the increase in MDR 
cases or not whereas Karl Pearson's correlation 
coefficient test was used to test whether there is 
significant correlation between MRSA and D-test.  
Results 
Growth pattern of culture and distribution of 
culture positive within the departments 
Out of 270 pus/wound swab samples, 139 (51.48%) were 
found to be culture positive while remaining 131 (48.52%) 
showed no growth. OPD showed highest positive culture 
118 (85%) compared to that of the IPD 21 (15%). Within 
the hospital department, highest growth was seen in the 
department of Neonates ICU (NICU) 100% (1/1) 
followed by Surgical ICU (SICU)75% (3/4), Infant ICU 
(IICU) 66.67% (4/6), OPD 51.75% (118/228), 
Surgical/Burn ward (S/B ward) 50% (6/12), General 
ward (GW) 41.67% (5/12), Pediatric ICU (PICU) 33.33% 
(1/3) and lowest in Special ward (Sp. ward) 25% (1/4) 
(Figure 1).  
Bacteriological profile of pus/wound swab 
In the study, 116 (83.5%) out of 139 were gram positive 
and 23 (16.5%) were gram negative. Out of total 139 
culture positive cases, S. aureus 105 (75.5%) was found to 
be common isolates followed by Escherichia coli 7 (5.04%) 
and Staphylococcus epidermidis 7 (5.04%); Pseudomonas 
aeruginosa 6 (4.3%); unidentified organism 4 (2.9%); 
Enterococcus 2 (1.45%), Proteus mirabilis 2 (1.45%) and 
Staphylococcus saprophyticus 2 (1.45%); Salmonella Typhi 1 
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(0.72%), Klebsiella oxytoca 1 (0.72%), Klebsiella pneumoniae 
1 (0.72%) and Citrobacter species 1 (0.72%) (Table 1).  
Figure 1. Distribution of culture positive cases within the 
departments. 
Table 1. Bacteriological profile of pus/wound swab 
Microorganism identified Number Percentage 
S. aureus 105 75.5% 
E. coli 7 5.04% 
Citrobacter spp. 1 0.72% 
P. aeruginosa 6 4.3% 
Enterococcus 2 1.45% 
S. saprophyticus 2 1.45% 
S. epidermidis 7 5.04% 
S. Typhi 1 0.72% 
P. mirabilis 2 1.45% 
K. oxytoca 1 0.72% 
K. pneumoniae 1 0.72% 
Unidentified 4 2.8% 
Total 139 100.00% 
Distribution of S. aureus according to the 
gender, age and within the hospital 
departments 
Among 105 positive sample showing S. aureus, 51% (54) 
were found to be female patient and 49% (51/105) were 
male patient. The highest prevalence of S. aureus was 
found among age group 12-15 yrs. 87.5% (7/8) followed 
by the age group 1-3 yrs. 84.21% (32/38), age group 1 
month-1 yrs. 76.92% (20/26), age group 6-12 yrs. 75% 
(24/32), 0-1 month 71.42% (10/14) and age group 4-6 yrs. 
57.14% (12/21) (Figure 2). Most of the S. aureus was 
highly isolated from IICU department 100% (4/4), PICU 
100% (1/1), NICU 100% (1/1) followed by GW 80% (4/5), 
OPD 78.81% (93/118), S/B ward 33.33% (2/6) and no S. 
aureus were isolated from Sp. ward) 0% (0/1) and SICU 
0% (0/3) (Table  2). 
 
Figure 2. Distribution of S. aureus within the age group of the 
patient 
Table 2. Distribution of S. aureus within hospital departments 
Departments S. aureus 
 Total Number Percentage 
OPD 118 93 78.81% 
General ward 5 4 80% 
Special ward 1 0 0% 
Surgical / burn ward 6 2 33.33% 
Infant ICU 4 4 100% 
Pediatric ICU 1 1 100% 
Surgical ICU 3 0 0% 
Neonates ICU 1 1 100% 
Total 139 105 75.5% 
Table 3. Antibiotic susceptible pattern of S. aureus (N= 105) 
Antibiotic used 
Antibiotic Susceptible Pattern 
Resistant Intermediate Sensitive 
Gentamycin 11(10%) 9(9%) 85(81%) 
Ciprofloxacin  71(68%) 10(10%) 24(23%) 
Chloramphenicol  4(4%) 4(4%) 97(92%) 
Cotrimoxazole 26(25%) 8(8%) 71(68%) 
Cefoxitin  58(55%) 0(0%) 47(45%) 
Erythromycin  58(55%) 18(17%) 29(28%) 
Clindamycin  28(27%) 2(2%) 75(71%) 
Piperacillin  4(4%) 5(5%) 96(91%) 
Meropenem  1(1%) 2(2%) 102(97%) 
Azithromycin  54(51%) 7(7%) 44(42%) 
Doxycycline  0(0%) 2(2%) 103(98%) 
Linezolid  1(1%) 0(0%) 104(99%) 
Vancomycin  9(9%) 0(0%) 96(91%) 
Antibiotic susceptibility pattern of S. aureus 
and Multidrug resistant (MDR) S. aureus  
While performing antibiotic susceptibility test (Figure 3), 
out of 105 S. aureus, 104 (99%) were found to be sensitive 
towards Linezolid followed by Doxycycline 103 (98%), 
Meropenem 102 (97%), Chloramphenicol  97 (92%) and 
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resistant towards Ciprofloxacin  71 (68%) followed by 
Cefoxitin 58 (55%) and Erythromycin  58 (55%) 
respectively (Table 3). In our study, 50% (52) were found 
to be multidrug resistant. Among multidrug resistant 
also, one strain was found to be resistant to all the 
antimicrobial agent used to be tested, i.e. extremely drug 
resistant (XDR).  
Figure 3. Antibiotic susceptibility test of Staphylococcus aureus 
on MHA. (VA = Vancomycin, AZM = Azithromycin, PTZ = 
Piperacillin, DOX = Doxycycline and LZ = Linezolid). 
Distribution of MRSA among S. aureus positive 
sample and its antibiotic susceptibility 
pattern 
In the study, 55% (58) were found to be Cefoxitin resistant 
showing Methicillin resistant strains (MRSA) whereas 
45% (47) were found to be Cefoxitin sensitive showing 
Methicillin sensitive strains (MSSA). All the resistant 
strains were further tested for Vancomycin susceptible 
test.  
Table 4. Antibiotic Susceptibility Pattern of MRSA (N=58) 
Antibiotics Resistant Intermediate Sensitive 
Cotrimoxazole 18(31.04%) 3(5.17%) 37(63.79%) 
Chloramphenicol 3(5.17%) 3(5.17%) 52(89.66%) 
Gentamycin 6(10.35%) 7(12.07%) 45(77.58%) 
Ciprofloxacin 51(87.93%) 6(10.35%) 1(1.72%) 
Clindamycin 21(36.21%) 0(0%) 37(63.79%) 
Erythromycin 38(65.53%) 8(13.79%) 12(20.68%) 
Piperacillin 4(6.9%) 4(6.9%) 50(86.20%) 
Meropenem 1(1.72%) 1(1.72%) 56(96.56%) 
Azithromycin 43(74.13%) 5(8.62%) 10(17.25%) 
Linezolid 1(1.72%) 0(0%) 57(98.28%) 
Doxycycline 0(0%) 2(3.44%) 56(96.56%) 
Vancomycin 9(15.52%) - 49(84.48%) 
Here, MRSA was found sensitive towards Linezolid 
98.28% (57) followed by Doxycycline 96.56% (56), 
Meropenem 96.56% (56), Chloramphenicol 89.66% (52), 
Piperacillin 86.20% (50), Vancomycin 84.48% (49), 
Gentamycin 77.58% (45), Cotrimoxazole 63.79% (37) and 
Clindamycin 63.79% (37). MRSA was found to be 
resistant towards Ciprofloxacin 87.93% (51) followed by 
Azithromycin 74.13% (43), Erythromycin 65.53% (38) and 
was found to be zero resistant towards Doxycycline. 
(Table 4).  
VRSA and MIC 
Among isolated S. aureus, 9 were found to be resistant 
towards the Vancomycin disc. While performing 
minimum inhibitory concentration test, all positive 
strains were found to be sensitive towards Vancomycin 
in a very low concentration, i.e. 0.25 µg/ml and minimum 
bactericidal concentration was found to be 0.25 µg/ml. 
Association between MDR and MRSA 
In the study, 44 (84.61%) MRSA were found to be MDR 
and 14 (26.42%) MRSA were found to be MDR negative. 
By analyzing the data of MDR and MRSA using chi-
square test, the value was found to be chi-square (1, 
N=105) =35.958, p˂.01. Therefore, MDR was found to be 
statistically significant associated with MRSA.  
D-test of S. aureus and Correlation between D-
test positive and MRSA  
In D-test (Figure 4), out of total 105 S. aureus identified, 
24 (22.86%) were found to be D-test positive, 21 (20.0%) 
were D-test negative, 31 (29.52%) were sensitive to both 
Erythromycin and Clindamycin and 29 (27.62%) were 
constitutive resistant (Table 5).  
Figure 4. Double disk diffusion test (D-test) on MHA medium 
showing sensitive (K) and positive result (L). CD = Clindamycin 
and E = Erythromycin) 
Table 5. Correlation between MRSA and D-test 
 D-test positive D-test negative Constitutive resistant Sensitive Total r  value 
MRSA 18  (75%) 8(38.1%) 20 (69%) 12 (38.71%) 58 0.39 
MSSA 6 (25%) 13 (61.9%) 9 (31%) 19 (61.29%) 47  
Total 24 21 29 31 105 (100%)  
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Here, 18 (75%) MRSA were D-test positive, 8 (38.1%) 
MRSA were D-test negative, 20 (69%) MRSA were 
constitutive resistant and 12 (38.71%) MRSA were 
sensitive as shown in Table 5. The correlation coefficient 
(r) between D-test and MRSA was found to be 0.39 (r = 
.313, p˂.01), i.e. D-test and MRSA was found to be 
positive but lowly correlated with each other.   
Discussion 
Out of total sample, 139 (51.48%) showed growth and 131 
(48.52%) showed no growth. The growth result was 
found nearly similar to the study conducted by 
Hanumanthappa et al, where they found 56% growth 
rate [32]. The result was lower to the study conducted by 
Rai et al [10] 58.6%; Khan et al [33] 65.2% and Patil et al 
[34] 86%. The lower growth might be due to difficult-to-
grow fastidious organisms, inappropriate methods of 
collection and transportation of specimens or the 
administration of antibiotics prior to specimen collection. 
Among 139 positive growth result, 118 (85.65%) were 
found to be positive from out-patient department and 21 
(14.4 %) from in-patient department. High prevalence of 
growth in OPD might be due to increase in community 
acquired infection. Higher positive growth in OPD was 
also found in the study carried by KC et al [35] and found 
contrary to the study carried out by Pant et al, where they 
found 63.1% from IPD and 56.2% from OPD [36].  
Out of total growth 139, 116 (83.5%) were found to be 
Gram-positive and 23 (16.5%) were found to be gram 
negative. The high prevalence of Gram-positive 
organism might be due to the presence of Gram-positive 
bacteria as a normal flora of the human body. The result 
was found to be similar to the research conducted by KC 
et al [35]; Devi et al [37] and Pant et al [36]. The result was 
found contrast to the study conducted by Patil et al 
(2019)78% gram negative and 22% Gram-positive 
bacteria [34].  
The predominance of S. aureus (75.5%) in the study might 
be due to S. aureus being normal flora of skin, glands, 
nails, etc. and having various virulence factors. The result 
was seems to be related to the study conducted by 
Sultana et al (2015) 40.45% S. aureus followed by E. coli 
28.18% [38]; Barakoti et al (2017) 41.45% S. aureus 
followed by E. coli 22.79% [39]; Bankar et al (2018) 34.21% 
S. aureus followed by E. coli 23.02%[40] and Shahi et al 
(2018)70.6% S. aureus [41]. However Mahat et al [42] and 
Patil et al [34] Pseudomonas spp. as predominant 
organism.  
The infection in the age group 12-15 yrs. might be due to 
the various activities performed in the school, 
environment, involved in fight, their playmates and 
contact with various object. The children under 5 years 
are also prone to get pus/wound infection because of 
unintentional falls, burns, etc. and not only that these 
group also has low immune power to overcome any kind 
of infection, therefore it is likely to get infected. The 
outcomes were found to be contrast with the study 
conducted in 2017 by Pokhrel et al, where they got higher 
prevalence of S. aureus in age group 1-3yrs [43]; Rai et al 
in age less than 1 year [10] and Pant et al in age group 1-
5yrs [36]. 
The distribution of S. aureus among gender was found to 
be high in female patient 54 (51%) than the male patient 
51 (49%). The finding resembled with the research 
conducted by Muluye et al [20] and Bhatt et al [44]. The 
result obtained from our study was contrast to the 
research conducted by Shrestha et al [28] and Garoy et al 
[45]. 
The high prevalence of S. aureus in ICU departments 
might be due to the colonization of S. aureus from 
patient's own flora, transmission through staff hands, air, 
procedure of surgery, inanimate object, longer period of 
hospital stays, etc. Similar study was carried out by 
Bhatta et al. (2014) who had reported higher prevalence 
of S. aureus in hospital setting accounting [44].  
S. aureus was found to be highly sensitive towards 
Linezolid (99%) followed by Doxycycline (98%). The 
outcome was found similar to the study conducted by 
Nirmala et al [2] of 100% sensitive towards Linezolid and 
Vancomycin and by Khan et al [33]. It was found to be a 
bit different from the research carried out in 2018 by 
Tadesse et al [46] in which they found 100% sensitive 
towards Ampicillin. 
From the study, out of 105 isolates, 52 (50%) were found 
to be MDR. Among MDR also one strain was found to be 
resistant to all the antimicrobial agents to be tested 
(Extremely drug-resistant). MDR cases may be due to 
accumulation of multiple genes, expression of genes that 
code for multidrug efflux pumps, extruding a wide range 
of drugs, mutational alteration of the target protein, 
enzymatic inactivation of drugs, etc. [47].  
Here, 44 (84.61%) MDR were found to be MRSA and 8 
(15.39%) MDR were found be MSSA. The increase in 
MDR in MRSA may be due to a distinctive feature of 
MRSA, i.e. their resistance to β-lactam antibiotics. 
Therefore, once the S. aureus is resistant to Methicillin, it 
may also show resistance towards other antibiotic classes 
like: aminoglycosides, macrolides, tetracycline, 
chloramphenicol and lincosamide. Our result was lower 
in comparison to Upreti et al [48] with 68.2% MDR, 
Pahadi et al [49] with 86.41% were MDR; Tadesse et al 
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[46] 82.3% MDR; whereas higher than he study 
conducted by Kadariya et al [50] with 44.2% were MDR 
and Mama et al with 27.8% were MDR [51]. 
The strong association between the MDR and MRSA was 
found (p˂.01) while performing Pearson chi-square test. 
Hence, we can say that the prevalence of MDR increases 
as the prevalence of MRSA increased. The data obtained 
from the research was found to be similar to the study 
conducted by Joachim et al in which 21.3% were MDR, 
out of which 72.7% of MRSA strains were MDR showing 
statistically significant association between MRSA and 
MDR among S. aureus isolates (p=0.001) [52].  
The prevalence of MRSA was found to be 58 (55%) and 
methicillin sensitive S. aureus (MSSA) was found to be 47 
(45%). The study resembles to the study carried out by 
Devi et al (2017), where 50.79% were MRSA and 49.21% 
were MSSA [37]. However, the study was in 
contradiction to the study carried by Kayastha et al (2010) 
8.92% MRSA [23]; Ansari et al (2014) 43.1% MRSA [53]; 
Jaiswal et al (2016) 72% MRSA [54] and Adhikari et al 
(2017) 35.50% MRSA [55].  
Since our research was conducted from September 2017 
to March 2018, the prevalence of MRSA seems to be 
increasing in Nepal as well [56, 53, 55, 57, 48, 45, 41]. The 
development of resistance of S. aureus towards 
Methicillin may be due to the acquisition of 
staphylococcal chromosome cassette mec (SCC mec) in its 
chromosome, which carries a mec A gene facilitating 
resistance to Methicillin via Penicillin binding protein 
(PBP-2a). Although the acquisition of the mecA gene, the 
organism cannot exhibit resistant towards Methicillin 
unless the gene is activated. 
MRSA was found to be sensitive towards Linezolid 
98.28% (57) followed by Doxycycline 96.56% (56) and 
resistant towards Ciprofloxacin 87.93% (51) followed by 
Azithromycin 74.13%. Similar sensitive pattern in MRSA 
was found in the study carried out by Choudhury et al 
(2016) in which organism was found sensitive towards 
Linezolid (99.3%), Vancomycin (99.3%) and resistant 
towards Cefuroxime (59.50%) [58].  
In our study, Vancomycin resistant was found to be 9% 
(9/105) from disc diffusion method but while performing 
the MIC, S. aureus was found to be 100% sensitive 
towards Vancomycin, i.e. 0.25 μg/ml and MBC was 
found to be 0.25 μg/ml. Hence, isolated S. aureus was 
found to be 100% susceptibility towards Vancomycin. 
Therefore, we need to perform MIC for the confirmation 
of Vancomycin resistant strain. The cause of Vancomycin 
resistance may be due to the activation of van A and van 
B gene. The finding was found to be similar to the 
research conducted by Kshetry et al, where organism was 
found sensitive towards Vancomycin while performing 
MIC test [59] and study by Bamigboye et al showed 1.4% 
VRSA but found to be van A and van B gene negative 
[25].  
From the study, only 22.86% (24) were found to be D-test 
positive, 20% (21) were found to be   D-test negative, 
29.52% (31) were found to be susceptible to both 
Erythromycin and Clindamycin and 27.62% (29) were 
found to be constitutive resistant. The resistance of the 
Erythromycin and Clindamycin may be due to the 
resistance encoded in Erythromycin methylase (erm) 
genes. The constitutive expression may be due to the 
organism being resistant to all macrolides, lincosamides 
and type B streptogramin antibiotics. The study 
resembled to the study carried out by Mama et al [51] 
with 24.1% D-test positive, 1% D-test negative, 2% 
constitutive D-test and 60.85% sensitive towards 
Erythromycin and Clindamycin. 
In this study, D-test positive was also seen high in MRSA 
75% (18/24) compare to the MSSA 25% (6/24). Similar 
result was obtained in research conducted by Pal et al 
[60]. The correlation (r) between D-test and MRSA was 
found to be 0.39 which means D-test and MRSA are 
positively but lowly correlated, i.e. D-test cases may 
increase as increase in MRSA cases. The result obtained 
was contrast with the study carried out by Gosh et al [61]. 
The increase in reported inducible Clindamycin resistant 
shows the increase in prevalence of inducible 
Clindamycin resistance along with constitutive resistant 
among the clinical isolates of S. aureus. Hence, the 
screening of inducible Clindamycin resistant should be 
done in every clinical laboratory.  
Conclusion 
Prevalence of wound infection was found to be high 
(51.48%) in our study. The growth rate was found high in 
OPD patient than IPD. S. aureus was predominant 
organism followed by E. coli and S. epidermidis. The 
prevalence of S. aureus was seen high in the age group of 
12-15 years. The cases were also seen high in the 
department of IICU, PICU, and NICU. High prevalence 
of MRSA was observed in this study. The isolates were 
sensitive mainly towards Linezolid, Doxycycline, 
Meropenem, and Chloramphenicol, Vancomycin. The 
organism was found highly resistant towards 
Ciprofloxacin. 50% of isolates were found to be MDR. 
Among MDR, one strain was found to be XDR. MDR was 
mainly found in MRSA than MSSA strain. Hence, all 
MRSA are considered as MDR. D-test positive cases was 
found higher in MRSA cases. Since, inducible D-test has 
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been reported, it is necessary to screen the inducible 
Clindamycin resistance before the prescription of the 
medication for the effective treatment of infection. 
Vancomycin, Linezolid, Doxycycline, Meropenem, and 
Chloramphenicol were effective drug for S. aureus and 
MRSA. 
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